Cell tracking with optical imaging

被引:151
作者
Sutton, Elizabeth J. [1 ]
Henning, Tobias D. [1 ]
Pichler, Bernd J. [4 ]
Bremer, Christoph [2 ,3 ]
Daldrup-Link, Heike E. [1 ]
机构
[1] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA
[2] Univ Munster, Dept Radiol, Munster, Germany
[3] Univ Munster, Interdisciplinary Ctr Clin Res FG3, Munster, Germany
[4] Univ Tubingen, Lab Preclin Imaging & Imaging Technol, Werner Siemens Fdn, Dept Radiol, Tubingen, Germany
关键词
optical imaging; cell tracking; fluorescent dyes; near infrared; in vivo; molecular imaging;
D O I
10.1007/s00330-008-0984-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Adaptability, sensitivity, resolution and non-invasiveness are the attributes that have contributed to the longstanding use of light as an investigational tool and form the basis of optical imaging (OI). OI, which encompasses numerous techniques and methods, is rapid (< 5 min), inexpensive, noninvasive, nontoxic (no radiation) and has molecular (single-cell) sensitivity, which is equal to that of conventional nuclear imaging and several orders of magnitude greater than MRI. This article provides a comprehensive overview of emerging applications of OI-based techniques for in vivo monitoring of new stem cell-based therapies. Different fluorochromes for cell labeling, labeling methods and OI-based cell-tracking techniques will be reviewed with respect to their technical principles, current applications and aims for clinical translation. Advantages and limitations of these new OI-based cell-tracking techniques will be discussed. Non-invasive mapping of cells labeled with fluorochromes or OI marker genes has the potential to evolve further within the clinical realm.
引用
收藏
页码:2021 / 2032
页数:12
相关论文
共 69 条
[11]   Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation [J].
Cao, YA ;
Bachmann, MH ;
Beilhack, A ;
Yang, Y ;
Tanaka, M ;
Swijnenburg, RJ ;
Reeves, R ;
Taylor-Edwards, C ;
Schulz, S ;
Doyle, TC ;
Fathman, CG ;
Robbins, RC ;
Herzenberg, LA ;
Negrin, RS ;
Contag, CH .
TRANSPLANTATION, 2005, 80 (01) :134-139
[12]   Tracking stem cells in the cardiovascular system [J].
Chemaly, ER ;
Yoneyama, R ;
Frangioni, JV ;
Hajjar, RJ .
TRENDS IN CARDIOVASCULAR MEDICINE, 2005, 15 (08) :297-302
[13]   Fluorescent proteins as a toolkit for in vivo imaging [J].
Chudakov, DM ;
Lukyanov, S ;
Lukyanov, KA .
TRENDS IN BIOTECHNOLOGY, 2005, 23 (12) :605-613
[14]   Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit [J].
Costa, GL ;
Sandora, MR ;
Nakajima, A ;
Nguyen, EV ;
Taylor-Edwards, C ;
Slavin, AJ ;
Contag, CH ;
Fathman, CG ;
Benson, JM .
JOURNAL OF IMMUNOLOGY, 2001, 167 (04) :2379-2387
[15]   Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy [J].
Daldrup-Link, HE ;
Rudelius, M ;
Metz, S ;
Piontek, G ;
Pichler, B ;
Settles, M ;
Heinzmann, U ;
Schlegel, J ;
Oostendorp, RAJ ;
Rummeny, EJ .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (09) :1312-1321
[16]   Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging [J].
Fowler, M ;
Virostko, J ;
Chen, ZY ;
Poffenberger, G ;
Radhika, A ;
Brissova, M ;
Shiota, M ;
Nicholson, WE ;
Shi, YB ;
Hirshberg, B ;
Harlan, DM ;
Jansen, ED ;
Powers, AC .
TRANSPLANTATION, 2005, 79 (07) :768-776
[17]   In vivo tracking of stem cells for clinical trials in cardiovascular disease [J].
Frangioni, JV ;
Hajjar, RJ .
CIRCULATION, 2004, 110 (21) :3378-3383
[18]   In vivo near-infrared fluorescence imaging [J].
Frangioni, JV .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2003, 7 (05) :626-634
[19]   Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents [J].
Frank, JA ;
Zywicke, H ;
Jordan, EK ;
Mitchell, J ;
Lewis, BK ;
Miller, B ;
Bryant, LH ;
Bulte, JWM .
ACADEMIC RADIOLOGY, 2002, 9 :S484-S487
[20]   A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction [J].
Freyman, T ;
Polin, G ;
Osman, H ;
Crary, J ;
Lu, MM ;
Cheng, L ;
Palasis, M ;
Wilensky, RL .
EUROPEAN HEART JOURNAL, 2006, 27 (09) :1114-1122